BiomX Inc.

NYSEAM:PHGE Stock Report

Market Cap: US$3.5m

BiomX Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PHGE?
Owner TypeNumber of SharesOwnership Percentage
Private Companies26,8531.76%
Individual Insiders76,6715.02%
Institutions273,58717.9%
Hedge Funds346,21722.7%
General Public803,31252.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 59.6%.

Top Shareholders

Top 25 shareholders own 47.38% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.6%
Cystic Fibrosis Foundation
131,269US$296.7k0%100.0%
8.6%
Deerfield Management Company, L.P.
131,268US$296.7k0%no data
8.6%
Nantahala Capital Management, LLC
131,226US$296.6k0%0.02%
5.48%
Alyeska Investment Group, L.P.
83,723US$189.2k0%no data
3.69%
Rodney Hodges
56,317US$127.3k0%no data
3.02%
AMR Action Fund GP, LLC
46,152US$104.3k0%no data
1.76%
Nimble Ventures, LLC
26,853US$60.7k0%no data
1.48%
JPMorgan Chase & Co.
22,631US$51.1k0%no data
1.38%
Dafna Capital Management, LLC
21,112US$47.7k0%0.01%
1.35%
Ikarian Capital, LLC
20,682US$46.7k-56%0.01%
0.62%
Jonathan Solomon
9,463US$21.4k0%no data
0.56%
Citadel Advisors LLC
8,514US$19.2k0%no data
0.38%
Merav Bassan
5,860US$13.2k0%no data
0.36%
Boothbay Fund Management, LLC
5,498US$12.4k-56%no data
0.35%
Renaissance Technologies LLC
5,390US$12.2k305%no data
0.33%
Johnson & Johnson Innovation - JJDC, Inc.
5,098US$11.5k0%no data
0.27%
ADAR1 Capital Management, LLC
4,087US$9.2k-74.1%no data
0.24%
Marina Wolfson
3,627US$8.2k0%no data
0.089%
Assaf Oron
1,358US$3.1k0%no data
0.086%
Barclays PLC
1,315US$3.0k0%no data
0.066%
Two Sigma Investments, LP
1,006US$2.3k0%no data
0.036%
Two Sigma Securities, LLC
556US$1.3k0.18%no data
0.0084%
UBS Asset Management AG
128US$289.10%no data
0.0078%
Clear Street LLC
119US$268.80%no data
0.0017%
Alan Moses
26US$58.70%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/06 10:33
End of Day Share Price 2026/01/05 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BiomX Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph PantginisH.C. Wainwright & Co.
I-Eh JenLaidlaw & Company (UK) Ltd